Wednesday, April 19, 2023 3:33:51 PM
Your thoughts here fits pretty well with some thoughts I emailed to the company, and I'll add on that here. My thoughts generally implied that IMO, iQSTEL needs to set a bottom price (likely not publicly shared) for which they would sell shares.
Maybe it's $.50, $1.00, or $2.00 or more, but mainly just don't take any less than that for shares pretty much for any reason whatsoever. In that sense they would establish a point at which they value the worth of their company.
If they can't get that price and want to do an acquisition, then don't do the acquisition. Or if their numbers are good enough maybe use conventual financing, again, only if it would pay off to do so. But not financing that involves warrants or options are any other device that pays off a lender in shares. Just a simple loan, and repayment of interest. If they can't get favorable terms then don't do that either.
Of course they do have to do what they must to keep operating until they are profitable, but they need to keep any sources of funding at as least toxic as possible. We are in Q2, so maybe they are already profitable or getting close to it, based on their 2023 guidance.
If the company sets a minimum level for selling shares, I think the market would likely take a hint at that towards deciding a fair value of the company. That is to say, if iQSTEL sets a price that they consider a fair value based on their inside knowledge. It may not be publicized, but eventually investors can see at what prices the company is able to sell its shares and might consider that as something of guide in determining the market worth of its shares.
In any case, I can't see how it does investors or the company much good to sell shares well below what the company believes that it is worth. Ultimately they control for how much they sell those shares.
Just some numbers for entertainment, but in December 2020 the share price hit a (then) recent low of $.071. When you look at the shares out and revenue at that time the price to sales ratio bottomed at about .19 of sales. At yesterdays low, and based on current shares and sales, the price to sales ratio hit about .18 of sales.
In the 2020 - early 2021 time frame price to sales went from about .19 to 5.27. A 1.0 price to sales would have been $.38 a share. With current data a 1.0 price to sales should see about $.56 a share.
Bottom in? I don't know. I bought a few more at $.11 this morning, but I have bought at levels all up and down the scale like many of you. That's just my plan, not investment advice as everyone needs to figure out how they see it and what they should do based on their own DD.
Recent IQST News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:56:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 10:19:27 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 02/13/2024 04:40:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 03:47:57 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/08/2024 02:18:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 08:37:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 05:28:56 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/30/2024 09:58:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 09:24:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 10:26:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 10:22:44 PM
- IQST - iQSTEL and QXTEL Announce a Deal To Become Quarter Billion Revenue Corporation • InvestorsHub NewsWire • 01/22/2024 02:56:12 PM
- Will Acquisition News Send Shares of this Telecom Firm Higher? • AllPennyStocks.com • 01/22/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 05:11:18 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/28/2023 08:29:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 05:12:58 PM
- Company Preparing for Uplisting Announces YTD Results • AllPennyStocks.com • 10/19/2023 03:50:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/28/2023 04:15:24 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 08:04:54 PM
- IQST - iQSTEL Signs $10M Term Sheet with LDA Capital to Back Nasdaq Uplist Plan • InvestorsHub NewsWire • 09/13/2023 02:03:11 PM
- IQST - iQSTEL Announces $83 Million YTD Revenue Besting Forecasted Rate • InvestorsHub NewsWire • 09/07/2023 01:22:35 PM
- IQST - iQSTEL Engages First Prospects For AI-Enhanced Metaverse App V1.2 • InvestorsHub NewsWire • 08/29/2023 04:57:24 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/25/2023 08:54:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 05:40:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2023 08:46:36 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM